GLP-1 Receptor Agonists

GLP-1 Drugs Linked to Lower Five-Year Death Risk in Colon Cancer, UCSD Study Finds

An observational review of more than 6,800 cases reports the strongest association in severe obesity, prompting calls for randomized trials to confirm any survival effect.